Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
A New Perspective on Amyloid Precursor Protein Processing: Rhomboid Protease-4 and Cholesterol in the Alzheimer Pathology
FY 2018-19
Summary
Alzheimer disease (AD) currently affects over 24 million people worldwide, and is defined by the presence of plaques in the brain comprised of protein fragments called amyloid beta (A?). It is well established that A? is formed through the consecutive cleavage of the amyloid precursor protein (APP) by two proteins in the cell membrane: ?- and ?-secretase. Recently, it has been shown that another protein called rhomboid intramembrane protease 4 (RHBDL4) is also able to cleave APP, and this RHBDL4-mediated cleavage prevents APP from reaching the cell membrane. Interestingly, it was just shown that this cleavage is likely regulated by the cholesterol content of the cell. When cholesterol levels are high, RHBDL4 activity is reduced, and vice versa. In cell models of AD, less A? has already been observed in conditions of low cholesterol, but it remains unclear why that is. This RHBDL4-mediated cleavage could provide insight into the mechanism behind this observation. It is hypothesized that the RHBDL4 cleavage of APP offsets the pathogenic ?-/?-secretase cleavage, and that this offset is influenced by cholesterol levels. This project aims to generate more robust results surrounding RHBDL4 cleavage of APP, and how cholesterol is involved. A new method will be developed to directly measure the activity of RHBDL4, and previous experiments will be repeated in a better cell model of AD. It is expected that when cholesterol levels are high, ?-/?-secretase cleavage will dominate, as a result of decreased RHBDL4 activity, ultimately resulting in more A?. Considering the high levels of cholesterol shown in brains of those affected by AD and the myriad of AD risk factors related to cholesterol, this research is vital in further connecting cholesterol to the AD pathology.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406460
Name
Rowe Elyn
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A New Perspective on Amyloid Precursor Protein Processing: Rhomboid Protease-4 and Cholesterol in the Alzheimer Pathology
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid Beta (Aß); Amyloid Precursor Protein (App); Cholesterol; Endoplasmic Reticulum (Er); Intramembrane Proteolysis; Neurodegneration; Plasma Membrane; Rhomboid Protease
Abstract
Alzheimer disease (AD) currently affects over 24 million people worldwide, and is defined by the presence of plaques in the brain comprised of protein fragments called amyloid beta (A?). It is well established that A? is formed through the consecutive cleavage of the amyloid precursor protein (APP) by two proteins in the cell membrane: ?- and ?-secretase. Recently, it has been shown that another protein called rhomboid intramembrane protease 4 (RHBDL4) is also able to cleave APP, and this RHBDL4-mediated cleavage prevents APP from reaching the cell membrane. Interestingly, it was just shown that this cleavage is likely regulated by the cholesterol content of the cell. When cholesterol levels are high, RHBDL4 activity is reduced, and vice versa. In cell models of AD, less A? has already been observed in conditions of low cholesterol, but it remains unclear why that is. This RHBDL4-mediated cleavage could provide insight into the mechanism behind this observation. It is hypothesized that the RHBDL4 cleavage of APP offsets the pathogenic ?-/?-secretase cleavage, and that this offset is influenced by cholesterol levels. This project aims to generate more robust results surrounding RHBDL4 cleavage of APP, and how cholesterol is involved. A new method will be developed to directly measure the activity of RHBDL4, and previous experiments will be repeated in a better cell model of AD. It is expected that when cholesterol levels are high, ?-/?-secretase cleavage will dominate, as a result of decreased RHBDL4 activity, ultimately resulting in more A?. Considering the high levels of cholesterol shown in brains of those affected by AD and the myriad of AD risk factors related to cholesterol, this research is vital in further connecting cholesterol to the AD pathology.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rowe, Elyn
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~